S

State of Wisconsin Investment Board

Manages public funds through investment portfolio

Corporate Governance Intern

Summer 2027Posted on 10/1/2026
No salary listed
Internship
Bachelor's
Madison, WI, USA
In Person

About the job

Requirements
  • Currently pursuing a bachelor's degree in economics, accounting, public policy, political science, business, or a related field.
  • Strong research and analytical skills, including the ability to investigate, understand, and summarize new or complex topics.
  • Strong attention to detail and organizational skills, and the ability to work independently.
  • Strong written and verbal communication skills, including the ability to clearly and concisely communicate research findings.
  • Proficiency with Microsoft Excel, including formulas, pivot tables, and organizing and analyzing data sets.
  • Familiarity with generative artificial intelligence tools, including ChatGPT, and their responsible use in research, data collection, and analysis.
Responsibilities
  • Collect, organize, and analyze executive compensation, proxy voting, director, and other governance data from proxy filings and other sources.
  • Research executive compensation practices and trends, including incentive structures, performance metrics, pay outcomes, and alignment with company performance.
  • Benchmark SWIB’s proxy voting guidelines and governance approaches against peer institutional investors and evolving market practices.
  • Research Securities and Exchange Commission rules, legislation, and other regulatory or market developments that may affect proxy voting, executive compensation, and corporate governance practices.
  • Analyze governance and compensation data to identify trends and support the team’s evaluation of proxy voting guidelines and stewardship approaches.
  • Summarize relevant company disclosures, academic and industry research, and other governance information.
  • Develop summary statistics, tables, charts, and other materials to communicate research and analytical findings.
  • Support additional corporate governance, proxy voting, engagement, data collection, and research projects as assigned.
Desired Qualifications
  • Experience with Python or other tools and techniques for extracting, organizing, or analyzing large data sets from regulatory filings, websites, PDFs, or other sources.

About the company

S

State of Wisconsin Investment Board

View

SWIB manages and invests Wisconsin’s public employee retirement funds and other state assets for residents. It pursues long-term investments across stocks, bonds, real assets, and alternatives using internal research, risk controls, and external managers to build diversified portfolios and meet actuarial targets while controlling costs. As a state agency, it operates with fiduciary responsibility to public funds, emphasizing prudent stewardship, transparency, and long-horizon investing at scale. Its goal is to maximize long-term returns for Wisconsin’s public retirement systems while keeping risk and costs in check to ensure stable funding for beneficiaries.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Madison, Wisconsin

Founded

1951

Get referred to State of Wisconsin Investment Board

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • SWIB reported $3.8B in five-year outperformance on March 20, 2026.
  • January 21, 2026 preliminary 2025 results reinforced strong pension-fund performance.
  • June 2026 private-market commitments added $3.5B across equity, debt, and real estate.

What critics are saying

  • Private-market marks and exits drive 2026 returns, leaving SWIB exposed through 2027.
  • A downturn in Wisconsin politics can reshape trustees, compensation, and hiring quickly.
  • Persistent underperformance would trigger benefit-pressure headlines and damage SWIB’s recruiting edge.

What makes State of Wisconsin Investment Board unique

  • SWIB manages $178B for Wisconsin pensions with deep internal investment teams.
  • In 2026, SWIB marked 75 years and $3.8B above benchmarks.
  • SWIB’s private-equity, debt, and real-estate program spans $27B-plus.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive benefits package

Educational and training opportunities

Tuition reimbursement

Hybrid work environment

Relocation Assistance

Professional Development Budget

Hybrid Work Options

Company News

PR Newswire
Nov 6th, 2025
Elephas Biosciences Raises $40M for Platform

Elephas Biosciences raised $40M in a Series B-2 funding round to accelerate the commercialization of its Elephas Live™ Platform, a live tumor profiling technology for predicting immunotherapy responses. The funding, supported by existing investors like Northpond Ventures and ARCH Venture Partners, will aid in launching the platform as a laboratory developed test in 2026. CEO Maneesh Arora highlighted the strong investor confidence and the company's progress towards improving cancer treatment.

PR Newswire
Jan 23rd, 2024
Elephas Announces $55 Million In Series C Funding

Company advancing novel live tumor imaging diagnostic platformMADISON, Wis., Jan. 23, 2024 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $55 million in Series C funding. Venture Investors Health Fund and State of Wisconsin Investment Board (SWIB) led the round. Continuing investments were made by Northpond Ventures, ARCH Ventures, Sands Capital, Moore Strategic Ventures, Tao Invest, and WARF Ventures. With this $55 million Series C funding, this brings the total raised by Elephas to $116.5 million.Elephas is developing an oncology imaging diagnostics platform to predict response to immunotherapy using the latest advances in metabolic imaging. The platform utilizes live patient biopsies with intact native tumor architecture and treats them with potential therapies to predict response to treatment

PR Newswire
Dec 13th, 2022
HistoSonics Announces $100 Million in Financings and New Appointment to its Board of Directors

/PRNewswire/ -- HistoSonics, Inc. (www.histosonics.com), the developer of a non-invasive, novel sonic beam therapy, announced today that it has raised $85...